Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 11, 2011 - Issue 7
Submit an article Journal homepage
30
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Progress and challenges in developing a molecular diagnostic test for neurofibromatosis type 1

Yolanda Martín Molecular Genetics Unit, University Hospital Ramón y Cajal, Institute of Health Research (IRYCIS), and the Center for Biomedical Research–Network of Rare Diseases (CIBERER), Carretera de Colmenar km 9.1, 28034 Madrid, Spain
,
Ana Dopazo Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain
&
Concepción Hernández-Chico Molecular Genetics Unit, University Hospital Ramón y Cajal, Institute of Health Research (IRYCIS), and the Center for Biomedical Research–Network of Rare Diseases (CIBERER), Carretera de Colmenar km 9.1, 28034 Madrid, Spain. [email protected]
Pages 671-673 | Published online: 09 Jan 2014

References

  • Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in South-East Wales. Brain111, 1355–1381 (1988).
  • Lee MJ, Stephenson DA. Recent developments in neurofibromatosis type 1. Curr. Opin. Neurol.20(2), 135–141 (2007).
  • Kehrer-Sawatzki H, Cooper DN. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? J. Med. Genet.45(10), 622–631 (2008).
  • Upadhyaya M. NF1 Gene structure: NF1 genotype/phenotype correlations. In: Neurofibromatoses. Monographs in Human Genetics (Volume 16). Kaufmann D (Ed.). Karger Basel, Switzerland 46–62 (2008).
  • Griffiths S, Thompson P, Frayling I, Upadhyaya M. Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam. Cancer6, 21–34 (2007).
  • Messiaen LM, Wimmer K. NF1 mutational spectrum. In: Neurofibromatoses. Monographs in Human Genetics (Volume 16). Kaufmann D (Ed.). Karger Basel, Switzerland 63–77 (2008).
  • Ars E, Serra E, García J et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet.9, 237–247 (2000).
  • Pros E, Gómez C, Martín T, Fábregas P, Serra E, Lázaro C. Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. Hum. Mutat.29, E173–E193 (2008).
  • Messiaen L, Callens T, Mortier G et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum. Mutat.15, 541–555 (2000).
  • Valero MC, Martín Y, Hernández-ImazE et al. A highly sensitive genetic protocol to detect NF1 mutations. J. Mol. Diagn.13(2), 113–122 (2011).
  • Shen MH, Mantripragada K, Dumanski JP, Frayling I, Upadhyaya M. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH. Clin. Genet.72(3), 238–244 (2007).
  • Pasmant E, Sabbagh A, Masliah-Planchon J et al. Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J. Mol. Diagn.11, 524–529. (2009).
  • Fahsold R, Hoffmeyer S, Mischung C et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet.66, 790–818 (2000).
  • Valero MC, Velasco E, Moreno F, Hernández-Chico C. Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE). Hum. Mol. Genet.3, 639–641 (1994).
  • Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet.24, 133–141 (2008).
  • Metzker ML. Sequencing technologies – the next generation. Nat. Rev. Genet.11, 31–46 (2010).
  • Huentelman MJ. Targeted next-generation sequencing: microdroplet PCR approach for variant detection in research and clinical samples. Expert Rev. Mol. Diagn.11(4), 347–349 (2011).
  • Mamanova L, Coffey AJ, Scott CE et al. Target-enrichment strategies for next generation sequencing. Nat. Methods.7, 111–118 (2010).
  • Nord AS, Lee M, King MC, Walsh T. Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics12, 184 (2011).
  • Levin JZ, Berger MF, Adiconis X et al. Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biol.10(10), R115 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.